Faeth Therapeutics, Inc.
FTH
Rank in Stocks
#14396
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Share Price
$12.68
Last synced: 2026-11-09
Market Cap
$326.87M
Change (1 day)
-42.49%
Change (1 year)
32.50%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Faeth Therapeutics, Inc. (FTH)
Category
Healthcare
EPS for Faeth Therapeutics, Inc. (FTH)
EPS as of September 2026 TTM: $-138.82
According to Faeth Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-138.82. At the end of 2025 the company had an EPS of $-16.72, an increase over its 2024 EPS of $-24.01.
EPS history for Faeth Therapeutics, Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-138.82 | 730.26% |
| 2025 | $-16.72 | -30.36% |
| 2024 | $-24.01 | -1.60% |
| 2023 | $-24.40 | -22.91% |
| 2022 | $-31.65 | 19.16% |
| 2021 | $-26.56 | 101.06% |
| 2020 | $-13.21 | -5.71% |
| 2019 | $-14.01 | 21.93% |
| 2018 | $-11.49 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -111.28% |
US
|
|
| $-7.07 | -94.91% |
US
|
|
| $-5.29 | -96.19% |
AU
|
|
| $12.88 | -109.28% |
BE
|
|
| $21.56 | -115.53% |
NL
|
Questions about Faeth Therapeutics, Inc.'s earnings per share (EPS)
What is Faeth Therapeutics, Inc.'s earnings per share (EPS)?
Faeth Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-138.82, as of Sep 2026.
What was Faeth Therapeutics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Faeth Therapeutics, Inc.'s earnings per share (EPS) was $-16.72, compared with $-24.01 in 2024.
How has Faeth Therapeutics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Faeth Therapeutics, Inc.'s earnings per share (EPS) was highest in 2020 ($-13.21) and lowest in 2022 ($-31.65).
How does Faeth Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
Faeth Therapeutics, Inc.'s earnings per share (EPS) ($-138.82) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.